Aprinoia

Home | APRINOIA Therapeutics

Taiwan · $51.1M raised

Business Model
B2B
Total Funding
$51.1M
Last Round
$40.0M Series CJan 2021
Rounds
2

About

APRINOIA is a clinical-stage biotech company committed to protecting patients' brain health and changing outcomes for a broad range of neurodegenerative diseases through best-in-class diagnostic tools and novel therapies. The company's name merges the Latin word for sunlight, "apricum," with the Greek suffix for mind, "noia," reflecting its mission to shed light on better ways to diagnose and treat these disorders.

Summary

Aprinoia is a Biotech company based in Taiwan. It has raised $51.1M in total across 2 rounds, most recently a $40.0M Series C round in Jan 2021. Investors include Daiwa Corporate Investment, KTB Network and DCI Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJan 2021
$40.0M

Sign up to see all 2 rounds

Series B through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aprinoia on Indexed.vc
<a href="https://indexed.vc/companies/aprinoia"><img src="https://indexed.vc/api/badge/company/aprinoia" alt="Aprinoia on Indexed.vc" width="260" height="76" /></a>